Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

  • Scientific challenges facing the TB vaccine field
  • Next Generation TB Vaccines and Vaccine Concepts
  • TB vaccine development

Related Conference of Tuberculosis Vaccines

February 27-28, 2025

8th International Conference on Vaccines and Immunology

Paris, France
April 28-29, 2025

2nd Global Summit on Vaccines & Emerging Diseases

Bali, Indonesia
July 28-29, 2025

43rd Euro Global Summit and Expo on Vaccines & Vaccination

Aix-en-Provence, France
September 18-19, 2025

7th World Congress on Vaccine and Immunology

Amsterdam, Netherlands

Tuberculosis Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in